Latest brain tumors Stories

NEW YORK, Nov. 12, 2012 /PRNewswire/ -- Voices Against Brain Cancer, in partnership with New York Road Runners, will host its annual "Join the Voices! Run/Walk" on Sunday, December 2, 2012 in Central Park, New York at 8:15 a.m. The charitable event will feature a five-mile run, a scenic walk, kids races and a fun family festival. American icon Tony Danza will act as the official Master of Ceremonies for the second year in a row. Participants of the "Join the Voices!...

Brett Smith for redOrbit.com - Your Universe Online Of the 6.4 billion nucleotides in the human genome, a single change from adenine to guanine at a specific location recently identified by geneticists can increase the odds of certain kinds of brain tumors by six times, according to the scientists’ report in the latest edition of the journal Nature Genetics. The results produced by researchers at the University of California at San Francisco (UCSF) and the Mayo Clinic could result in...

Death of first wife makes things more personal for scientist working to improve quality of life of brain tumor patients receiving radiation therapy WINSTON-SALEM, N.C., June 26, 2012 /PRNewswire-USNewswire/ -- The following is being released by Wake Forest Baptist Medical Center HealthWire: (Logo: http://photos.prnewswire.com/prnh/20111114/DC06171LOGO) Mike Robbins knows all too well the likely outcome when patients are diagnosed with brain tumors that are "high grade." The median...

Pediatric brain tumors preserve specific characteristics of the normal cells from which they originate – a previously unknown circumstance with ramifications for how tumor cells respond to treatment. This has been shown by Uppsala researcher Fredrik Swartling together with colleagues in the U.S., Canada and England in a study that was published today in the distinguished journal Cancer Cell. Every year, 80-90 children in Sweden are afflicted with brain tumors, a serious form of pediatric...

As National Brain Tumor Awareness Month begins, the National Brain Tumor Society and Accelerate Brain Cancer Cure will rally staff, family members, patients and advocates to urge Members of Congress to increase funding for the National Institutes of Health (NIH) and support the Cancer Drug Coverage Parity Act (HR 2746) tomorrow. In a time of heated debate over the budget and significant changes to the healthcare system, the Group hopes to put a face to these issues and acquire the support...

ABTA Recognizes May as Brain Tumor Awareness Month Chicago, IL (PRWEB) May 01, 2012 May is Brain Tumor Awareness Month. In acknowledgement of this time of increased attention and awareness, the American Brain Tumor Association (http://www.abta.org) offers these “Top Ten” facts and statistics about brain tumors: 1)    More than 600,000 people in the United States are currently living with a brain tumor—approximately 209 out of every 100,000 people....

Inaugural Event to be Held November 10, 2012 (PRWEB) April 13, 2012 The American Brain Tumor Association (ABTA) has announced the date and location for its inaugural New York City “Breakthrough for Brain Tumors” 5K Run/Walk. The all-ages event will take place on Saturday, November 10, 2012 at Hudson River Park, Pier 84, in New York City, and will feature a chip-timed, certified 5K (3.1 mile) run followed by an untimed walk. This is the ABTA’s first expansion of the its signature...

A vast majority of cells in the brain are glial, yet our understanding of how they are generated, a process called gliogenesis, has remained enigmatic. Researchers at Baylor College of Medicine have identified a novel transcripitonal cascade that controls these formative stages of gliogenesis and answered the longstanding question of how glial cells are generated from neural stem cells. "Most people are familiar with neurons, cells that process and transmit information in the brain. Glial...

Imaging amino acid transporters with positron emission tomography/computed tomography (PET/CT) has been shown to significantly alter intended management plans for patients with brain tumors, according to research in the March issue of The Journal of Nuclear Medicine. As a result of imaging with the radiopharmaceutical 3,4-dihydroxy-6-F-18-fluoro-l-phenylalanine (F-18-DOPA), physicians changed the intended management plan for 41 percent of patients with brain tumors. Contrast-enhanced...

Medulloblastomas are the most common cancerous (malignant) brain tumors in children. Although survival rates have improved over the years, medulloblastoma remains associated with substantial mortality, and long-term survivors often suffer debilitating effects from the intensive treatments. A team of researchers, led by Cecilia Söderberg-Nauclér and John Inge Johnsen, at the Karolinska Institutet, Sweden, has now identified a potential target for a more cancer-specific approach to treating...